日报更新时间：
周报更新时间：06-25 22:35
今开价：72.53
最高价：73.72
成交量：264641.0
昨收价：72.7
最低价：71.53
最新价：73.54
中文名称：斯达外科手术
英文名称：Staar Surgical
行业：服务业
简介：Staar Surgical Company设计、开发、制造并售卖可植入镜头
电话：1-626-3037902
STAAR Surgical Company连同旗下子公司设计、开发、生产和销售用于眼部的植入性镜片及植入镜片至眼睛的激光系统，STAAR Surgical公司提供：1、Visian——植入性隐形镜片（ICL），治疗视力障碍，如近视，远视，散光，老花；远视植入性隐形镜片（ICL），治疗远视。2、提供微创人工晶体（IOL），其中包括折叠式人工晶体，用于微创白内障手术；非球面人工晶体，可呈现比传统球面镜片更清晰的图像；nanoFLEX人工晶体，一种单片的非球面隐形镜片；环面人工晶体，提供白内障患者及使用于白内障手术中的预载注射器。3、此外，STAAR Surgical Company销售外科产品，其他相关仪器和设备，注射器零组件及制造用于治疗青光眼的AquaFlow设备。STAAR Surgical Company以STAAR®、EVO Visian ICL、Evolution in Visual Freedom、Visian、Collamer、CentraFLOW、AquaPORT、nanoFLEX、nanoPOINT 和 Afinity品牌（商标）销售其产品给医疗照护公司，包括手术中心、医院、管理式照护服务提供商、医疗机构、集体采购组织及政府机构。STAAR Surgical Company通过其在美国，日本，西班牙，德国，加拿大，英国和新加坡的销售代表直接销售产品，并通过约75个国家的独立分销商销售产品。斯达外科手术STAAR Surgical Company(STAA)历史百科：STAAR®为白内障手术开发，获得专利并获得第一个折叠式人工晶状体（IOL）的许可。由可弯曲材料制成的可折叠人工晶状体首次允许外科医生用微创手术取代白内障患者的天然晶状体。可折叠人工晶体成为全世界白内障手术的标准护理。1991年，STAAR推出了第一个由硅胶制成的隐形眼镜。1996年，STAAR开始在美国以外销售VisianICL®。由STAAR专有的生物相容性Collamer®晶状体材料制成的ICL植入虹膜后面和患者天然晶状体前面，以治疗屈光不正，如近视，远视和散光。ICL于1997年获得CE认证，允许在需要欧盟CE标志的国家销售，并于2005年12月获得美国FDA批准用于治疗近视。STAAR在60多个国家销售EVO Visian ICL和Visian ICL系列隐形眼镜，并已被全球超过80万客户使用。
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2019-06-19 | Wall (William P) | Director | Buy | 4254 | -- |
| 2019-06-19 | Silverman (Louis) | Director | Buy | 2127 | -- |
| 2019-06-19 | Moore (John C) | Director | Buy | 4254 | -- |
| 2019-05-05 | Moore (John C) | Director | Buy | 7500 | 1.92 |
| 2019-05-02 | BROADWOOD PARTNERS L P | Beneficial Owner of More than 10% Class | Buy | 100000 | 22.23 |
| 2019-04-03 | Andrews (Deborah J) | Chief Financial Officer | Sell | 1000 | 34.35 |
| 2019-03-21 | Holliday (Keith Ph.D.) | Chief Technology Officer | Sell | 3125 | 38.89 |
| 2019-03-21 | Gesten (Samuel J) | Officer | Sell | 1688 | 38.87 |
| 2019-03-21 | Andrews (Deborah J) | Chief Financial Officer | Sell | 833 | 38.88 |
| 2019-03-18 | Mason (Caren L) | Chief Executive Officer | Sell | 7500 | 36.25 |
| 2019-03-18 | Gesten (Samuel J) | Officer | Sell | 1500 | 36.20 |
| 2019-03-18 | Holliday (Keith Ph.D.) | Chief Technology Officer | Sell | 2084 | 36.22 |
| 2018-09-30 | BROADWOOD PARTNERS L P | Beneficial Owner of More than 10% Class | Sell | 114549 | -- |
| 2018-08-19 | Wall (William P) | Director | Sell | 5000 | 41.35 |
| 2018-06-13 | Moore (John C) | Director | Buy | 3691 | -- |
| 2018-06-13 | Farrell (Stephen C) | Director | Buy | 3691 | -- |
| 2018-06-13 | Wall (William P) | Director | Buy | 3691 | -- |
| 2018-05-06 | Andrews (Deborah J) | Chief Financial Officer | Buy | 25000 | 5.68 |
| 2018-05-02 | Andrews (Deborah J) | Chief Financial Officer | Sell | 13331 | 17.60 |
| 2018-05-02 | Andrews (Deborah J) | Chief Financial Officer | Buy | 13331 | 2.91 |
| 2018-03-21 | Holliday (Keith Ph.D.) | Chief Technology Officer | Sell | 2188 | 16.03 |
| 2018-03-21 | Andrews (Deborah J) | Chief Financial Officer | Sell | 333 | 16.05 |
| 2018-03-21 | Gesten (Samuel J) | Officer | Sell | 2833 | 16.05 |
| 2018-03-19 | Holliday (Keith Ph.D.) | Chief Technology Officer | Sell | 1458 | 16.05 |
| 2018-03-18 | Mason (Caren L) | Chief Executive Officer | Sell | 6667 | 16.09 |
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| SSGA Funds Management Inc | 404293 | 0.91% | -- | -- | 2019-07-31 |
| State Street Corporation | 1136094 | 2.55% | 86296 | 8.22% | 2019-03-31 |
| Vanguard Investments Australia Ltd | 1233916 | 2.77% | 102 | 0.01% | 2019-07-31 |
| BlackRock Fund Advisors | 1570679 | 3.53% | -101092 | -6.05% | 2019-07-31 |
| Baillie Gifford & Co Limited. | 1774201 | 3.99% | 68680 | 4.03% | 2019-03-31 |
| BlackRock Inc | 2960201 | 6.66% | -150884 | -4.85% | 2019-03-31 |
| Vanguard Group Inc | 3628164 | 8.16% | 28259 | 0.78% | 2019-03-31 |
| Palo Alto Investors, LLC | 4218902 | 9.49% | 70914 | 1.71% | 2019-03-31 |
| BROADWOOD CAPITAL Inc | 10740630 | 24.15% | -- | -- | 2019-03-31 |
| Northern Trust Investments Inc | 831109 | 1.87% | 10949 | 1.33% | 2019-07-31 |
| Waddell & Reed Financial Inc | 773868 | 1.74% | 773868 | -- | 2019-03-31 |
| Waddell & Reed Investment Management Co | 773868 | 1.74% | 773868 | -- | 2019-03-31 |
| TIAA-CREF Investment Management LLC | 408304 | 0.92% | 42610 | 11.65% | 2019-03-31 |
| State Street Global Advisors | 417155 | 0.94% | 300 | 0.07% | 2019-07-31 |
| Geode Capital Management, LLC | 445561 | 1.00% | -370273 | -45.39% | 2019-03-31 |
| Goldman Sachs Group Inc | 455189 | 1.02% | 214497 | 89.12% | 2019-03-31 |
| Bridger Management LLC | 514105 | 1.16% | -- | -- | 2019-03-31 |
| Northern Trust Investments N A | 533516 | 1.20% | 2739 | 0.52% | 2019-03-31 |
| Northern Trust Corp | 533516 | 1.20% | 2739 | 0.52% | 2019-03-31 |
| Renaissance Technologies Corp | 745900 | 1.68% | -529900 | -41.53% | 2019-03-31 |
| Marshall Wace Asset Management Ltd | 403060 | 0.91% | 250893 | 164.88% | 2019-03-31 |
| BlackRock Asset Management Canada Ltd | 973940 | 2.19% | -720 | -0.07% | 2019-05-31 |
| Millennium Management LLC | 494011 | 1.11% | -388482 | -44.02% | 2018-12-31 |
| Deutsche Bank AG | 384631 | 0.87% | 14736 | 3.98% | 2018-12-31 |
| Fidelity Management & Research Company | 388221 | 0.87% | 22581 | 6.18% | 2019-04-30 |
| Two Sigma Investments LLC | 393603 | 0.89% | 70510 | 21.82% | 2018-12-31 |
| Schonfeld Strategic Advisors LLC | 380946 | 0.86% | 38246 | 11.16% | 2018-12-31 |
| Fuller & Thaler Asset Management Inc | 361771 | 0.82% | -30178 | -7.70% | 2018-12-31 |
| Marshall Wace North America LP | 507072 | 1.15% | 507072 | -- | 2018-09-30 |
| Amvescap Plc. | 325004 | 0.74% | 183849 | 130.25% | 2018-09-30 |
| Putnam Investments LLC | 480238 | 1.09% | -2018632 | -80.78% | 2018-09-30 |
| Putnam Investment Management, LLC | 480238 | 1.09% | -2018632 | -80.78% | 2019-01-31 |
| D. E. Shaw & Co LP | 411400 | 0.93% | 327625 | 391.08% | 2018-06-30 |
| BlackRock Institutional Trust Company NA | 1002389 | 2.27% | -73883 | -6.86% | 2018-06-30 |
| Putnam Investment Management,LLC | 2498870 | 5.66% | -3774269 | -60.17% | 2018-06-30 |
| Next Century Growth Investors LLC | 507871 | 1.15% | 382710 | 305.77% | 2018-06-30 |
| Principal Global Investors, LLC | 215081 | -- | 7051 | 3.39% | 2018-06-30 |
| AQR Capital Management LLC | 256131 | -- | 256131 | -- | 2018-06-30 |
| State Street Corp | 751793 | -- | 21242 | 2.91% | 2018-06-30 |
| Broadwood Partners LP | 10881079 | -- | 10881079 | -- | 2018-08-01 |
| Cortina Asset Management LLC | 199927 | -- | -197150 | -49.65% | 2018-06-30 |
| Oberweis Asset Management Inc | 184020 | -- | 184020 | -- | 2018-06-30 |
| Grandeur Peak Global Advisors, LLC | 183841 | -- | -8825 | -4.58% | 2018-06-30 |
| Advisory Research Inc | 128322 | 0.31% | 128322 | -- | 2018-06-30 |
| EAM Investors | 128820 | 0.31% | 128820 | -- | 2018-06-30 |
| King Luther Capital Management Corp | 157230 | 0.38% | -6160 | -3.77% | 2018-06-30 |
| Northern Trust Asset Management | 101718 | 0.24% | -245 | -0.24% | 2018-07-31 |
| BNY Mellon Investment Management | 98429 | 0.24% | 1177 | 1.21% | 2018-06-30 |
| Mercer Global Investments Europe Limited | 89913 | 0.21% | 6530 | 7.83% | 2018-06-30 |
| Candriam Belgium | 93000 | 0.22% | -20000 | -17.70% | 2018-05-31 |
| Morgan Stanley & Co Inc | 144809 | 0.35% | -17243 | -10.64% | 2018-03-31 |
| Rice Hall James & Associates, LLC | 157759 | 0.38% | -7336 | -4.44% | 2017-12-31 |
| TIVERTON ASSET MANAGEMENT LLC | 137273 | 0.33% | -- | -- | 2018-03-31 |
| Millrace Asset Group Inc | 122767 | 0.30% | 122767 | -- | 2017-09-30 |
| Menta Capital LLC | 203634 | 0.49% | -2687 | -1.30% | 2017-09-30 |
| Columbia Mangmt Investment Advisers, LLC | 1232843 | 3.09% | 1232843 | -- | 2015-12-31 |
| Morgan Stanley Smith Barney LLC | 329655 | 0.81% | -266441 | -44.70% | 2016-09-30 |
| Archon Capital Management LLC | 299790 | 0.74% | -52910 | -15.00% | 2016-09-30 |
| BlackRock Advisors LLC | 158183 | 0.39% | 6880 | 4.55% | 2016-09-30 |
| Coe Capital Management, LLC | 130092 | 0.32% | 130092 | -- | 2016-09-30 |
| Ameriprise Financial,Inc. | 2146443 | 5.00% | 18588196 | 0.10% | 1999-11-30 |
| Blackrock,Inc. | 2237742 | 5.00% | 19378846 | 0.10% | 1999-11-30 |
| Palo Alto Investors,LLC | 3214253 | 5.00% | 27835431 | 0.10% | 1999-11-30 |
| Putnam Investments,LLC | 5759039 | 5.00% | 49873278 | 0.20% | 1999-11-30 |
| Broadwood Partners,L.P. | 7417582 | 5.00% | 64236260 | 0.20% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| State Street Russell Small/Mid Cap | 188727 | 0.42% | -- | -- | 2019-07-31 |
| Vanguard Extended Market Index Fund | 391870 | 0.88% | -1985 | -0.50% | 2019-06-30 |
| iShares Russell 2000 Growth ETF | 407485 | 0.91% | 4656 | 1.16% | 2019-07-30 |
| Waddell & Reed - Small Cap Grow Sel-UBS | 495963 | 1.11% | 495963 | -- | 2019-03-31 |
| Vanguard Small Cap Index | 573852 | 1.29% | -4268 | -0.74% | 2019-06-30 |
| Baillie Gifford Global Discovery Fund | 618958 | 1.39% | -- | -- | 2019-05-31 |
| Ivy Small Cap Growth Fund | 678400 | 1.52% | 314000 | 86.17% | 2019-06-30 |
| iShares Russell 2000 ETF | 983838 | 2.21% | 16061 | 1.66% | 2019-07-30 |
| Vanguard Total Stock Market Index Fund | 1225644 | 2.75% | 150 | 0.01% | 2019-06-30 |
| SPDR | 366942 | 0.82% | -- | -- | 2019-07-31 |
| Edinburgh Worldwide | 360870 | 0.81% | 421 | 0.12% | 2019-04-30 |
| American Funds SMALLCAP World Fund | 350800 | 0.79% | 350800 | -- | 2019-06-30 |
| Vanguard Explorer Fund | 201482 | 0.45% | -- | -- | 2019-03-31 |
| TIAA-CREF Quant Small-Cap Equity Fund | 203500 | 0.46% | -- | -- | 2019-06-30 |
| Vanguard Market Neutral Fund | 225012 | 0.51% | -31043 | -12.12% | 2019-03-31 |
| CREF Stock Account | 242614 | 0.54% | -83275 | -25.55% | 2019-06-30 |
| Vanguard Strategic Small Cap Equity Fund | 243240 | 0.55% | -- | -- | 2019-03-31 |
| Pru Ret Small Cap Growth/TimesSquare SP | 260000 | 0.58% | 260000 | -- | 2019-06-30 |
| AMG TimesSquare Small Cap Growth Fund | 260000 | 0.58% | 20000 | 8.33% | 2019-06-30 |
| Vanguard Small Cap Growth Index Fund | 330137 | 0.74% | 1159 | 0.35% | 2019-06-30 |
| NT R2000 Growth Index Fund - Non-Lending | 185079 | 0.42% | -6223 | -3.25% | 2019-06-30 |
| Ivy Small Cap Core Fund | 216205 | 0.49% | 216205 | -- | 2019-03-31 |
| iShares US Medical Devices ETF | 192636 | 0.43% | -- | -- | 2019-05-31 |
| iShares US Small Cap ETF (CAD-Hedged) | 899222 | 2.02% | -1512 | -0.17% | 2019-05-30 |
| Vanguard Small Cap Index Fund | 579745 | 1.30% | 7950 | 1.39% | 2019-04-30 |
| State Street Russell Small Cap | 180731 | 0.41% | 3446 | 1.94% | 2019-02-28 |
| Fidelity | 156702 | 0.35% | 24485 | 18.52% | 2019-01-31 |
| Hodges Small Cap Fund | 150000 | 0.34% | -50000 | -25.00% | 2018-12-31 |
| Buffalo Small Cap Fund | 136245 | 0.31% | 13600 | 11.09% | 2018-12-31 |
| iShares Micro-Cap ETF | 107545 | 0.24% | -- | -- | 2019-02-28 |
| Principal SmallCap Fund | 97800 | 0.22% | 2800 | 2.95% | 2019-01-31 |
| LKCM Small Cap Eq Fund | 121390 | 0.27% | -- | -- | 2018-12-31 |
| Fuller & Thaler Small Cap Core Eq | 268870 | 0.61% | 235670 | 709.85% | 2018-12-31 |
| Buffalo Discovery Fund | 105120 | 0.24% | 105120 | -- | 2018-09-30 |
| Putnam Capital Spectrum Fund | 180847 | 0.41% | -757712 | -80.73% | 2018-09-30 |
| Putnam Equity Spectrum Fund | 299391 | 0.68% | -1260920 | -80.81% | 2018-09-30 |
| Artemis US Smaller Companies Fund | 164110 | 0.37% | -- | -- | 2018-09-30 |
| Invesco DWA Healthcare Momentum ETF | 117528 | 0.27% | -- | -- | 2018-12-30 |
| Grandeur Peak Global Opportunities Fund | 104122 | 0.24% | 725 | 0.70% | 2018-07-31 |
| X MSCI USA Swap ETF | 130672 | 0.30% | 130672 | -- | 2018-08-31 |
| Fidelity Spartan | 124453 | 0.30% | 6983 | 5.94% | 2018-07-31 |
| CREF Stock R1 | 141400 | 0.34% | -32569 | -18.72% | 2018-07-31 |
| iShares Micro-Cap | 111313 | 0.26% | -- | -- | 2018-09-12 |
| PowerShares DWA Healthcare Momentum ETF | 117666 | 0.28% | -- | -- | 2018-09-13 |
| Vanguard Extended Market Idx Inv | 353026 | 0.84% | 2700 | 0.77% | 2018-07-31 |
| iShares Russell 2000 Growth | 398644 | 0.93% | -384 | -0.10% | 2018-09-12 |
| Vanguard Total Stock Mkt Idx | 792595 | 1.89% | -- | -- | 2018-07-31 |
| Putnam Capital Spectrum A | 938559 | 2.24% | -- | -- | 2018-06-30 |
| LKCM Small Cap Equity Instl | 121390 | 0.29% | -- | -- | 2018-06-30 |
| PowerShares DWA SmallCap Momentum ETF | 62676 | 0.15% | -- | -- | 2018-09-13 |
| Northern Trust Russell 2000 Index Fund - DC - Non-Lending | 101718 | 0.24% | -245 | -0.24% | 2018-07-31 |
| Putnam Equity Spectrum A | 1560311 | 3.73% | -3774269 | -70.75% | 2018-06-30 |
| BlackRock Russell 2000 | 61419 | 0.15% | 61 | 0.10% | 2018-06-30 |
| AXA 2000 Managed Volatility K | 62594 | 0.15% | -- | -- | 2018-07-31 |
| American Beacon Small Cp Val Inst | 65151 | 0.16% | -4047 | -5.85% | 2018-07-31 |
| Vanguard Health Care ETF | 67869 | 0.16% | 576 | 0.86% | 2018-07-31 |
| The Vanguard Russell 2000 Growth Index | 74827 | 0.18% | 1233 | 1.68% | 2018-07-31 |
| Schwab Small Cap Index | 78000 | 0.19% | -- | -- | 2018-07-31 |
| Principal SmallCap R2 | 92800 | 0.22% | 2700 | 3.00% | 2018-07-31 |
| Vanguard Strategic Small-Cap Equity Inv | 101397 | 0.24% | 101397 | -- | 2018-06-30 |
| BlackRock Russell 2500 | 58010 | 0.14% | 114 | 0.20% | 2018-06-30 |
| Grandeur Peak Global Opportunities Instl | 103397 | 0.25% | -74475 | -41.87% | 2018-04-30 |
| Principal SmallCap SP | 54780 | 0.13% | -- | -- | 2018-05-31 |
| State Street Russell Small/Mid Cap Idx Fd Cl I | 129525 | 0.32% | 9068 | 7.53% | 2017-06-30 |
| Vanguard Russell 2000 ETF | 45127 | 0.11% | 660 | 1.48% | 2018-05-31 |
| Vanguard Instl Ttl Stk Mkt Idx InstlPls | 42792 | 0.10% | -- | -- | 2018-05-31 |
| TIAA-CREF Small-Cap Blend Idx Inst | 48836 | 0.12% | -- | -- | 2017-11-30 |
| Rice Hall James Micro Cap Instl | 43200 | 0.10% | -- | -- | 2017-11-30 |
| Grandeur Peak Global Reach Instl | 57611 | 0.14% | -- | -- | 2016-10-31 |
| iShares Russell 2000 (AU) | 615003 | 1.60% | -774 | -0.10% | 2015-11-19 |
| Parvest Equity World Health Care | 347713 | 0.90% | -15949 | -4.40% | 2015-09-30 |
| Mutual of America Small Cap Growth Fund | 194843 | 0.50% | -- | -- | 2015-06-30 |
| Vanguard US Discoveries Fund | 152640 | 0.40% | -140809 | -48.00% | 2015-07-31 |
| Vanguard VIF Small Comp Gr | 150587 | 0.40% | -- | -- | 2015-09-30 |
| Columbia Small Cap Core Fund | 875052 | 2.20% | -- | -- | 2015-09-30 |
| Grandeur Peak Global Reach Fund | 123875 | 0.30% | -- | -- | 2015-07-31 |
| Fidelity Spartan® Extended Mkt Indx Fd | 105540 | 0.30% | -- | -- | 2015-09-30 |
| Principal SmallCap Blend SP | 137680 | 0.40% | -- | -- | 2015-10-31 |
| William Walter Goodmen | William Walter Goodmen occupies the position of Vice President-Global Human Resources at STAAR Surgical Co. In his past career Mr. Goodmen was EVP-Human Resources & Administration at THQ, Inc., Partner at Center for Corporate Innovation, Inc., Vice President-Business Development at Neovia Integrated Insurance Services, Inc. and Executive Vice President-Human Resources for Liberty Livewire Corp. Mr. Goodmen received an undergraduate degree from Colgate University and a graduate degree from Syracuse University. |
|---|---|
| Caren L. Mason | Caren L. Mason is a businessperson who has been the head of 5 different companies and currently occupies the position of President, Chief Executive Officer & Director at STAAR Surgical Co. Ms. Mason is also on the board of HealthTell, Inc., Advanced Medical Technology Association and Franciscan Sisters of the Poor Foundation, Inc. In the past she occupied the position of President & Chief Executive Officer at Quidel Corp., Senior Vice President-Bayer Corporate Health Care at Bayer AG, Chief Executive Officer & Director at Verinata Health, Inc., Chief Executive Officer at eMed Technologies Corp., President & Chief Executive Officer at MiraMedica, Inc., General Manager for GE Medical Systems Cesk�0�1�0�3 Republika sro and Senior VP-Technical Imaging Business Group at Agfa Corp. Caren L. Mason received an undergraduate degree from Indiana University. |
| Deborah J. Andrews | Presently, Deborah J. Andrews holds the position of Chief Financial Officer of STAAR Surgical Co. She is also on the board of BioTime, Inc. Ms. Andrews previously was Internal Auditor of Bourns, Inc., Vice President-Finance at STAAR Surgical AG and Auditor for KPMG Peat Marwick LLP. Ms. Andrews received an undergraduate degree from California State University-San Bernardino. |
| Samuel J. Gesten | Presently, Samuel J. Gesten is Secretary & Chief Legal Officer for STAAR Surgical Co. Mr. Gesten is also on the board of Serica Technologies, Inc. and UCP of Orange County. In the past he held the position of Vice president & Deputy General Counsel at Thermo Fisher Scientific, Inc. and Executive Vice President & General Counsel of Allergan, Inc. Samuel J. Gesten received an undergraduate degree from Brandeis University and a graduate degree from Boston University School of Law. |
| Louis E. Silverman | Louis E. Silverman is a businessperson who has been at the helm of 5 different companies and presently holds the position of Chairman at STAAR Surgical Co., Chairman & Chief Executive Officer at Advanced ICU Care, Inc. and Chairman for Comarco, Inc. He is also on the board of PatientPay, Inc. In his past career Mr. Silverman occupied the position of President & Chief Executive Officer of NextGen Healthcare, Inc., Chief Operating Officer at CorVel Corp., Chief Executive Officer-LifeComm Division at QUALCOMM, Inc. and Chief Executive Officer at Marina Medical Billing Services, Inc. He received an undergraduate degree from Amherst College and an MBA from Harvard Business School. |
| Stephen C. Farrell | Stephen C. Farrell holds the position of Chief Executive Officer & Director at Convey Health Solutions, Inc. and Chief Executive Officer at United States Pharmaceutical Group LLC (a subsidiary of Convey Health Solutions, Inc.). He is also on the board of STAAR Surgical Co., BioTime, Inc. and Brewster Academy. In his past career he was President, COO, CFO & Chief Compliance Officer at PolyMedica Corp., Chief Financial Officer & Executive Vice President of Stream Global Services, Inc. and Vice President & Senior Manager at PricewaterhouseCoopers LLP. Mr. Farrell received an undergraduate degree from Harvard University and an MBA from the University of Virginia Darden School of Business. |
| William P. Wall | William P. Wall is on the board of STAAR Surgical Co., Haynes International, Inc. and Capital International Ltd. (California) and Managing Member at Oq Partners LLC. In his past career Mr. Wall held the position of Managing Member at Ottauquechee Partners LLC, Associate for Ropes & Gray LLP, Partner at Andover Capital Advisors LP, Director & General Counsel at Nations Equipment Finance LLC, Managing Director at Fidelity Capital Investors, Inc., Director & General Counsel at Automile Holdings LLC, Director & General Counsel at Abrams Capital International Ltd. and General Counsel at Abrams Capital Management LLC. William P. Wall received an undergraduate degree from the University of Massachusetts and a graduate degree from Harvard University. |
| Jon K. Hayashida | Jon K. Hayashida is Vice President-Medical Affairs & Global Clinical at STAAR Surgical Co. Dr. Hayashida previously was Vice President-Clinical & Medical Affairs at Bausch + Lomb, Inc., Vice President-Clinical Affairs at Transcend Medical, Inc., Vice President-Clinical Affairs at WaveTec Vision Systems, Inc., Vice President-Clinical Affairs at Refractec, Inc., Vice President-Global Clinical Affairs at CooperVision, Inc., Principal at Allergan, Inc., Principal at Jules Stein Eye Institute, Principal at The National Board of Medical Examiners, Inc. and Vice President-Programs & Services at Braille Institute of America, Inc. Dr. Hayashida received an undergraduate degree and a doctorate from the University of Southern California. |
| John C. Moore | Currently, John C. Moore occupies the position of Chief Technical Officer at Tearsolutions LLC. Mr. Moore is also on the board of STAAR Surgical Co. In the past Mr. Moore was Chairman of Optovue, Inc., Chief Executive Officer at Notal Vision Ltd., Principal at Coherent, Inc., President & Chief Executive Officer for Laser Diagnostic Technologies, Inc., Principal at Carl Zeiss AG and Vice President at Alcon Laboratories, Inc. Mr. Moore received an undergraduate degree from the University of Rochester. |
| Hans-Martin Blickensdoerfer | Presently, Hans-Martin Blickensdoerfer occupies the position of SVP-Commercial Operations, Europe & China at STAAR Surgical Co. In his past career Mr. Blickensdoerfer was Commercial Director-Europe, Middle East & Africa at Novartis AG, Vice President-Sales & Marketing at Milvella Ltd. and Area Sales Manager-Central & Eastern Europe at Bausch + Lomb, Inc. He received a graduate degree from the University of Mannheim. |
| Graydon Hansen | Graydon Hansen is Senior Vice President-Global Operations at STAAR Surgical Co. In the past he held the position of Operations Director at Electro Energy, Inc. |
| Keith Holliday | Keith Holliday holds the position of Chief Technology Officer at STAAR Surgical Co. In his past career Dr. Holliday held the position of Vice President-Research & Development for ReVision Optics, Inc., Director-Laser Technology at Advanced Medical Optics, Inc., Principal at AMO Manufacturing USA LLC and Principal at Swiss Federal Institute of Technology. He received an undergraduate degree from the University of St. Andrews and a doctorate from Australian National University. |
| Philippe Subrin | Philippe Subrin is Vice President-ICL Manufacturing at STAAR Surgical Co. In the past he held the position of Manufacturing Manager at Bausch & Lomb France SAS and Vice President-Manufacturing at STAAR Surgical AG. Mr. Subrin received an undergraduate degree from the University of Lyon. |
| James E. Francese | James E. Francese is SVP-Commercial Operations at STAAR Surgical Co. In the past Mr. Francese occupied the position of Vice President-Asia Pacific Region at Abbott Medical Optics, Inc. Mr. Francese received an undergraduate degree from Cornell University, a graduate degree from the University of Washington and an MBA from the University of Southern California. |
| Denise McEachern | Denise McEachern is Head-Regulatory Affairs & Quality Assurance at STAAR Surgical Co. In her past career Ms. McEachern occupied the position of Vice President-Global Regulatory Affairs at Bausch + Lomb, Inc. She received a graduate degree from Concord Law School and an undergraduate degree from Washington College. |
| Graydon Hansen | Graydon Hansen is Senior Vice President-Global Operations at STAAR Surgical Co. In the past he held the position of Operations Director at Electro Energy, Inc. |
| Surindra Mann | Surindra Mann is VP-Global Financial Planning & Analysis at STAAR Surgical Co. |
| Scott D. Barnes | Currently, Scott D. Barnes is Chief Medical Officer at STAAR Surgical Co. Dr. Barnes is also Chief Ophthalmology Services Officer at Womack Army Medical Center. He received an undergraduate degree from Wheaton College (Illinois) and a doctorate from Northwestern College (Illinois). |
| Brian Moore | Currently, Brian Moore occupies the position of Head-Investor Relations of STAAR Surgical Co. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论